Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 28 studies | 22% ± 6% | |
| endothelial cell | 16 studies | 24% ± 9% | |
| basal cell | 11 studies | 35% ± 16% | |
| epithelial cell | 10 studies | 38% ± 20% | |
| myofibroblast cell | 9 studies | 20% ± 4% | |
| connective tissue cell | 9 studies | 24% ± 9% | |
| pericyte | 9 studies | 22% ± 6% | |
| ciliated cell | 9 studies | 30% ± 14% | |
| goblet cell | 8 studies | 28% ± 12% | |
| progenitor cell | 7 studies | 22% ± 7% | |
| adipocyte | 7 studies | 25% ± 9% | |
| oligodendrocyte precursor cell | 7 studies | 31% ± 11% | |
| mesothelial cell | 6 studies | 25% ± 15% | |
| club cell | 6 studies | 26% ± 6% | |
| neuron | 6 studies | 43% ± 16% | |
| astrocyte | 6 studies | 26% ± 6% | |
| oligodendrocyte | 6 studies | 24% ± 4% | |
| glutamatergic neuron | 5 studies | 45% ± 18% | |
| brush cell | 5 studies | 32% ± 11% | |
| type I pneumocyte | 5 studies | 23% ± 5% | |
| type II pneumocyte | 5 studies | 20% ± 4% | |
| GABAergic neuron | 5 studies | 42% ± 13% | |
| secretory cell | 4 studies | 27% ± 15% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 2% | |
| capillary endothelial cell | 4 studies | 16% ± 1% | |
| smooth muscle cell | 4 studies | 17% ± 1% | |
| natural killer cell | 4 studies | 20% ± 3% | |
| retinal rod cell | 4 studies | 24% ± 4% | |
| abnormal cell | 4 studies | 28% ± 12% | |
| enteroendocrine cell | 4 studies | 28% ± 15% | |
| interneuron | 4 studies | 40% ± 17% | |
| type B pancreatic cell | 3 studies | 34% ± 9% | |
| B cell | 3 studies | 24% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 1% | |
| T cell | 3 studies | 27% ± 8% | |
| neural crest cell | 3 studies | 19% ± 2% | |
| retinal bipolar neuron | 3 studies | 32% ± 12% | |
| microglial cell | 3 studies | 18% ± 1% | |
| retinal cone cell | 3 studies | 33% ± 9% | |
| lymphocyte | 3 studies | 19% ± 5% | |
| OFF-bipolar cell | 3 studies | 18% ± 1% | |
| ON-bipolar cell | 3 studies | 20% ± 1% | |
| glycinergic amacrine cell | 3 studies | 22% ± 7% | |
| rod bipolar cell | 3 studies | 26% ± 7% | |
| Schwann cell | 3 studies | 22% ± 4% | |
| intestinal crypt stem cell | 3 studies | 18% ± 2% | |
| macrophage | 3 studies | 18% ± 2% | |
| hematopoietic stem cell | 3 studies | 19% ± 1% | |
| luminal hormone-sensing cell of mammary gland | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 4953.90 | 21 / 21 | 100% | 51.69 | 504 / 504 |
| ovary | 100% | 7021.84 | 180 / 180 | 100% | 52.86 | 430 / 430 |
| pancreas | 100% | 3435.48 | 328 / 328 | 100% | 39.78 | 178 / 178 |
| prostate | 100% | 8787.29 | 245 / 245 | 100% | 69.90 | 502 / 502 |
| skin | 100% | 8223.95 | 1809 / 1809 | 100% | 33.02 | 472 / 472 |
| stomach | 100% | 4337.32 | 359 / 359 | 100% | 36.10 | 286 / 286 |
| thymus | 100% | 7989.30 | 653 / 653 | 100% | 59.11 | 605 / 605 |
| uterus | 100% | 8615.10 | 170 / 170 | 100% | 48.00 | 459 / 459 |
| esophagus | 100% | 4337.06 | 1444 / 1445 | 100% | 28.78 | 183 / 183 |
| intestine | 100% | 6098.46 | 966 / 966 | 100% | 42.43 | 526 / 527 |
| breast | 100% | 6212.62 | 459 / 459 | 100% | 48.29 | 1115 / 1118 |
| kidney | 100% | 6709.04 | 89 / 89 | 100% | 28.61 | 898 / 901 |
| lung | 100% | 4309.20 | 576 / 578 | 100% | 33.61 | 1155 / 1155 |
| adrenal gland | 100% | 6397.59 | 258 / 258 | 99% | 36.25 | 228 / 230 |
| brain | 98% | 4798.91 | 2602 / 2642 | 100% | 56.77 | 705 / 705 |
| liver | 100% | 3157.34 | 226 / 226 | 98% | 21.81 | 398 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 42.90 | 29 / 29 |
| spleen | 100% | 5988.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 35.02 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 48.13 | 1 / 1 |
| adipose | 100% | 4522.51 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3914.78 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 2918.19 | 839 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 90% | 16.84 | 72 / 80 |
| peripheral blood | 83% | 2150.27 | 769 / 929 | 0% | 0 | 0 / 0 |
| muscle | 82% | 1475.64 | 655 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032958 | Biological process | inositol phosphate biosynthetic process |
| GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
| GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
| GO_0043647 | Biological process | inositol phosphate metabolic process |
| GO_0050821 | Biological process | protein stabilization |
| GO_1905396 | Biological process | cellular response to flavonoid |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0001650 | Cellular component | fibrillar center |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030054 | Cellular component | cell junction |
| GO_0005634 | Cellular component | nucleus |
| GO_0052836 | Molecular function | inositol 5-diphosphate pentakisphosphate 5-kinase activity |
| GO_0000832 | Molecular function | inositol hexakisphosphate 5-kinase activity |
| GO_0000829 | Molecular function | inositol heptakisphosphate kinase activity |
| GO_0000828 | Molecular function | inositol hexakisphosphate kinase activity |
| GO_0000827 | Molecular function | inositol-1,3,4,5,6-pentakisphosphate kinase activity |
| GO_0052839 | Molecular function | inositol diphosphate tetrakisphosphate kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0097243 | Molecular function | flavonoid binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | IP6K2 |
| Protein name | Inositol hexakisphosphate kinase 2 (InsP6 kinase 2) (InsP6K2) (EC 2.7.4.-) (P(i)-uptake stimulator) (PiUS) Kinase (EC 2.7.-.-) Inositol hexakisphosphate kinase 2 |
| Synonyms | IHPK2 TCCCIA00113 |
| Description | FUNCTION: Converts inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). . |
| Accessions | ENST00000449610.5 ENST00000412795.5 ENST00000424035.1 ENST00000449563.5 ENST00000416707.1 [Q9UHH9-3] ENST00000413298.5 [Q9UHH9-2] ENST00000413654.5 ENST00000431721.6 [Q9UHH9-4] C9J124 C9J8W6 C9JU99 C9J536 ENST00000446860.5 [Q9UHH9-5] ENST00000433104.2 ENST00000443853.5 ENST00000455545.5 ENST00000417896.1 C9JRM0 C9JHV2 ENST00000437427.5 C9JGK2 ENST00000440424.5 ENST00000450045.5 C9JMC9 C9JHX0 C9JLG7 ENST00000340879.8 [Q9UHH9-2] ENST00000412850.5 Q9UHH9 ENST00000454335.5 C9J3W9 ENST00000432678.6 [Q9UHH9-6] ENST00000328631.10 [Q9UHH9-1] ENST00000434860.1 F8WDQ5 ENST00000443964.1 C9J790 ENST00000453202.1 |